Skip to content
Home/Companies/Biotech/iDEL Therapeutics
IT

iDEL Therapeutics

Biotech·Germany·Active·1yr hold

iDEL Therapeutics is a biotech company, headquartered in Germany.

Entry
2025
Hold
1yr
Status
Active
Est. EV
–

Who owns iDEL Therapeutics?

iDEL Therapeutics is currently owned by Gruenderfonds Ruhr through Gruenderfonds Ruhr II (2024 vintage), since 2025.

Hand-verified · updated 2026-07-03

Gruenderfonds Ruhr
Investor
Gruenderfonds Ruhr
Gruenderfonds Ruhr II · 2024 · VC

Key facts

HQGermany
SectorBiotech
StatusActive

More from Gruenderfonds Ruhr II

Other portfolio companies in the same fund.

CyberDesk
Active
SoftwareGermany· 2026
Factor2 Energy
Active
EnergyGermany· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings